By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Integrated BioPharma, Inc.

Integrated BioPharma, Inc. (INBP)

OTC Currency in USD
$0.29
+$0.01
+3.57%
Last Update: 11 Sept 2025, 15:23
$8.79M
Market Cap
7.09
P/E Ratio (TTM)
Forward Dividend Yield
$0.19 - $0.42
52 Week Range

INBP Stock Price Chart

Explore Integrated BioPharma, Inc. interactive price chart. Choose custom timeframes to analyze INBP price movements and trends.

INBP Company Profile

Discover essential business fundamentals and corporate details for Integrated BioPharma, Inc. (INBP) to support your stock research and investment decisions.

Sector

Consumer Defensive

Industry

Packaged Foods

IPO Date

30 Oct 1996

Employees

147.00

CEO

Riva Kay Sheppard

Description

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

INBP Financial Timeline

Browse a chronological timeline of Integrated BioPharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 12 May 2026

Upcoming earnings on 11 Feb 2026

Upcoming earnings on 11 Nov 2025

Earnings released on 14 May 2025

EPS came in at $0.02 , while revenue for the quarter reached $13.95M .

Earnings released on 13 Feb 2025

EPS came in at $0.00 , while revenue for the quarter reached $12.61M .

Earnings released on 13 Nov 2024

EPS came in at $0.01 , while revenue for the quarter reached $25.86M .

Earnings released on 20 Sept 2024

EPS came in at $0.01 , while revenue for the quarter reached $12.75M .

Earnings released on 10 May 2024

EPS came in at $0.01 , while revenue for the quarter reached $13.15M .

Earnings released on 12 Feb 2024

EPS came in at -$0.01 , while revenue for the quarter reached $11.51M .

Earnings released on 9 Nov 2023

EPS came in at -$0.00 , while revenue for the quarter reached $25.00M .

Earnings released on 15 Sept 2023

EPS came in at $0.00 , while revenue for the quarter reached $12.99M .

Earnings released on 11 May 2023

EPS came in at $0.00 , while revenue for the quarter reached $13.10M .

Earnings released on 10 Feb 2023

EPS came in at $0.03 , while revenue for the quarter reached $12.25M .

Earnings released on 10 Nov 2022

EPS came in at -$0.00 , while revenue for the quarter reached $12.33M .

Earnings released on 13 Sept 2022

EPS came in at $0.05 , while revenue for the quarter reached $13.27M .

Earnings released on 12 May 2022

EPS came in at $0.02 , while revenue for the quarter reached $15.63M .

Earnings released on 10 Feb 2022

EPS came in at $0.03 , while revenue for the quarter reached $14.59M .

Earnings released on 10 Nov 2021

EPS came in at $0.02 , while revenue for the quarter reached $12.75M .

Earnings released on 2 Sept 2021

EPS came in at $0.14 , while revenue for the quarter reached $17.06M .

Earnings released on 13 May 2021

EPS came in at $0.04 , while revenue for the quarter reached $17.07M .

Earnings released on 12 Feb 2021

EPS came in at $0.04 , while revenue for the quarter reached $14.26M .

Earnings released on 12 Nov 2020

EPS came in at $0.03 , while revenue for the quarter reached $15.17M .

Earnings released on 24 Sept 2020

EPS came in at $0.06 , while revenue for the quarter reached $13.54M .

INBP Stock Performance

Access detailed INBP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run